Kejadian Ikutan Pasca Imunisasi pada Anak
DOI:
https://doi.org/10.33143/jhtm.v8i2.2484Abstract
Salah satu pengendalian yang sudah dilakukan oleh Pemerintah adalah memulai vaksinasi anak berusia 6-11 tahun. Adapun reaksi simpang dari vaksin covid 19 yang dikenal sebagai Kejadian Ikutan Pasca Imunisasi (KIPI) atau Adverse Events Following Immunization (AEFI) adalah kejadian medik yang berhubungan dengan imunisasi baik berupa efek vaksin ataupun efek samping, toksisitas, reaksi sensitivitas, efek farmakologis, atau akibat kesalahan program, koinsidensi, reaksi suntikan, atau hubungan kausal yang tidak dapat ditentukan. Pemerintah meminta para orangtua tidak panik ketika mendapati anaknya mengalami indikasi gejala kejadian ikutan pasca imunisasi (KIPI) usai mendapat suntikan vaksin Covid-19. Beberapa indikasi gejala tersebut seperti nyeri pada lengan bekas suntikan, sakit kepala, nyeri otot, nyeri sendi, menggigil, mual atau muntah, rasa lelah, demam yang ditandai suhu diatas 37,8 derajat celsius, maupun gejala mirip flu dan menggigil selama 1 – 2 hari. Langkah penanganan dini yang dimaksud ialah membuat anak cukup beristirahat dan minum obat penurun panas jika diperlukan. Serta upayakan agar anak mengkonsumsi air putih yang cukup. Lalu, jika terdapat rasa nyeri di tempat bekas suntikan, usahakan tetap gerakan dan gunakan lengan anak. Setelah melakukan penanganan dini, orang tua agar segera melaporkan temuan KIPI yang dialami anak ke Puskesmas atau ke sentral vaksinasi. Hal ini akan menjadi input evaluasi pelaksanaan vaksinasi kedepannya serta penanganan lebih lanjut. Tujuan penelitian : untuk melakukan evaluasi monitoring kejadian ikutan pasca imunisasi Covid-19 pada anak. Rancangan penelitian ini menggunakan desain penelitian analitik dengan pendekatan cross sectional. Tahapan penelitian ini dimulai dengan penentuan subjek penelitian yaitu anak Sekolah Dasar di Kecamatan Syiah Kuala Banda Aceh 2.709 orang. Dikarenakan jumlah subjek penelitian yang berjumlah besar, maka ditentukan rumus jumlah sampel yaitu sebanyak 268 orang siswa SD di Kecamatan Syiah Kuala Banda Aceh, setelahnya peneliti melakukan wawancara terhadap responden dengan menggunakan kuesioner. Hasil pengumpulan data diolah dan dianalisa secara univariate dan bivariate menggunakan uji chi-square untuk menunjukkan adanya kejadian ikutan pasca imunisasi covid-19 pada anak.
Kata kunci: kejadian ikutan pasca imunisasi, anak
One of the controls that has been carried out by the Government is to start vaccinating children aged 6-11 years. The adverse reactions from the COVID-19 vaccine, known as Adverse Events Following Immunization (AEFI) are medical events related to immunization, either in the form of vaccine effects or side effects, toxicity, sensitivity reactions, pharmacological effects, or other consequences. program error, coincidence, injection reaction, or undetermined causal relationship. The government asks parents not to panic when they find their children have symptoms of post-immunization follow-up (AEFI) after receiving the Covid-19 vaccine. Some of the indications for these symptoms include pain in the injection site, headache, muscle aches, joint pain, chills, nausea or vomiting, fatigue, fever marked by a temperature above 37.8 degrees Celsius, or flu-like symptoms and chills for 1-2 day. The early treatment step in question is to make the child get enough rest and take fever-reducing medication if needed. And try to get your child to drink enough water. Then, if there is pain at the injection site, try to keep moving and use the child's arm. After carrying out early treatment, parents should immediately report the findings of AEFI experienced by the child to the Puskesmas or to the vaccination center. This will be an input for evaluating the implementation of vaccination in the future as well as further handling. The purpose of the study: to evaluate the monitoring of co-occurrence after Covid-19 immunization in children. The design of this study used an analytical research design with a cross sectional approach. This research stage begins with determining the research subject, namely elementary school children in Syiah Kuala District, Banda Aceh 2,709 people. Due to the large number of research subjects, the formula for the number of samples was determined, namely as many as 268 elementary school students in Syiah Kuala District, Banda Aceh, after which the researchers conducted interviews with respondents using questionnaires. The results of data collection were processed and analyzed univariately and bivariately using the chi-square test to show the occurrence of post-covid-19 immunization in children.
Keywords: post-immunization adverse events, children
References
Kemenkes. Status Vaksin. 2021. from: https://vaksin.kemkes.go.id/#vaccines.
Keputusan Menteri Kesehatan Republik Indonesia Nomor HK.01.07/Menkes/12758/2020 tentang Penetapan Jenis Vaksin Untuk Pelaksanaan Vaksinasi Corona Virus Disease 2019 (COVID-19)
Keputusan Menteri Kesehatan Republik Indonesia Nomor 19 tahun 2021 tentang Perubahan kedua atas Peraturan Menteri Kesehatan nomor 10 tahun 2021 tentang Pelaksanaan Vaksinasi dalam Rangka Penanggulangan Pandemi Corona Virus Disease 2019 (COVID-19)
UNICEF. Booklet Vaksin COVID-19 dan KIPI.
Badan POM RI. 2020. Penerbitan Persetujuan Penggunaan dalam Kondisi Darurat atau Emergency Use Authorization (EUA) Pertama Untuk Vaksin COVID-19. Jakarta: BPOM RI.
Ruiz JB, et al,. Predictors of intention to vaccinate against COVID-19. Vaccine. 2020.
Kemenkes RI. Peraturan Menteri Kesehatan Republik Indonesia Nomor 84 tahun 2020 tentang Pelaksanaan Vaksinasi dalam Rangka Penanggulangan Pandemi Corona Virus Disease 19 (COVID-19(. Jakarta: Kemenkes RI; 2020.
Ahad. 2021. Pemerintah Fokus Lakukan Vaksinasi COVID-19. from www.republika.co.id; https://www.republika.co.id/berita/qmcvhf467/2021-pemerintah-fokus-lakukan-vaksinasi-covid19.
Downloads
Issue
Section
License
I. ORIGINALITY, AUTHORSHIP, AND COPYRIGHT
The manuscripts submitted for publication must be research works written in English that have not been previously published and  are not being considered for publication elsewhere. All the authors must have agreed to the submission and to the order of their names on the title page. They must also have agreed that the corresponding author may act on their behalf throughout the editorial review and publication process. The corresponding author is responsible for obtaining such agreement.
Requests for changes in authorship (order of listing or addition or deletion of names) after submission should be accompanied by signed statements of agreement from all the parties involved. To maintain and protect the publisher‘s ownership and rights and to protect the original authors from misappropriations of their published work, author(s) are required to sign a Journal Publishing Agreement and send it to the editorial office (jhtm@uui.ac.id).
II. PERMISSION
The author is responsible for acquiring the permission(s) to reproduce any copyrighted figures, tables, data, or text that are being used in the submitted paper. Authors should note that text quotations of more than 250 words from a published or copyrighted work will require grant of permission from the original publisher to reprint. The written permission letter(s) must be submitted together with the manuscript.
III. EDITORIAL REVIEW AND REVISION
All papers will be critically read by at least two anonymous reviewers, selected for their competence in the subject area of the paper. Acceptance of the paper will depend upon its scientific merit and suitability for the journal. A paper may be accepted in its original form or subject to revision.
The reviewers' (and editor's) suggestions will be conveyed to the author, who will then have an opportunity to revise the paper. A manuscript returned to an author for revision can be held for a maximum of eight weeks.
The accepted paper will be edited by native English speakers. The cost of language editing service is currently free.
IV. PROOFS
Galley proofs (PDF format) for an accepted article will be sent by e-mail to the corresponding author for copyediting corrections. The core content of an article cannot be changed at this time. It is the author's responsibility to check the entire manuscript, including tables, figure legends, and cited reference numbers, not just the items queried. The proofs should be corrected and mailed to the editorial office within 48 hours of receipt in order to expedite publication. Only one set of corrections will be accepted. In other words, it is important to ensure that all of your corrections are sent to us in one communication.
V. Â REPRINTS
Five free reprint copies of the published article will be shipped to the corresponding authors in Indonesia only, approximately two weeks after the issue is printed. Authors, including overseas authors, who wish to purchase reprints, are required to complete the Reprint Order Form, which will be sent with the galley proofs to corresponding authors. This form must be returned together with the corrected galley proofs.
